Poplar Therapeutics

Biotech · Private

Next-generation anti-IgE monoclonal antibody therapeutic

poplartx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3213P2D, INC——
3214Artios Pharma——
3215HAWA THERAPEUTICS LLC——
3216Poplar Therapeutics——
3217MULTITARGA LLC——
3218Shield Pharma LLC——
3219QWIXEL THERAPEUTICS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.